unknown
Stage
1
Investors
About
Vivan Therapeutics develops personalized cancer therapeutics using genomics-based drug screening technology. The company replicates patients' genetic profiles to screen thousands of drug combinations, aiming to identify effective treatments tailored to individual tumor networks.
Explore Vivan Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.